NCT00000195
Withdrawn
Phase 2
Neurobiology of Opioid Dependence: 4
ConditionsOpioid-Related Disorders
DrugsNaltrexone
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Opioid-Related Disorders
- Sponsor
- Yale University
- Locations
- 1
- Primary Endpoint
- Behavioral, physiological, neuroendocrine response to yohimine
- Status
- Withdrawn
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Behavioral, physiological, neuroendocrine response to yohimine
Study Sites (1)
Loading locations...
Similar Trials
Withdrawn
Phase 2
Neurobiology of Opioid Dependence: 5 - 5Opioid-Related DisordersNCT00000196Yale University
Completed
Phase 4
The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of DreamsNeuroscience of Dreaming, HealthyNCT02792140University of Bern32
Completed
Phase 2
Effects of Naltrexone on Nicotine ReinforcementTobacco DependenceNCT00270231University of Pennsylvania64
Withdrawn
Phase 2
Neurobiology of Opioid Dependence: 1 - 1Opioid-Related DisordersNCT00000192Yale University
Withdrawn
Phase 2
Neurobiology of Opioid Dependence: 3 - 3Opioid-Related DisordersNCT00000194Yale University